Do not use hydroxychloroquine for COVID: National Taskforce The strengthened recommendation stems from studies that show a lack of efficacy and potential harmful side effects.
Retracted Lancet study ‘a wake-up call’ It is not the first time a journal has retracted a paper. But with such glaring discrepancies, will it affect how people view the peer-review process?
Questions over WHO decision to pause global hydroxychloroquine trial Studies drawing on data collected by a little-known US company have been called into question by the medical community.
Australian hydroxychloroquine trial to continue despite WHO ‘pause’ High-risk healthcare workers will continue taking the anti-malaria drug as part of a clinical trial testing its ability to protect against COVID-19, a lead investigator told newsGP.
Hydroxychloroquine drug trial set for high-risk healthcare workers The first gold standard Australian clinical trial to determine whether the drug can help prevent COVID-19 is now open.
Deputy CMO requests GP assistance Professor Paul Kelly has written to RACGP President Dr Harry Nespolon to ask for general practice’s help in managing the current supply shortage of hydroxychloroquine.
New coronavirus drug trial commences across Australia The first trial site has opened at the Royal Melbourne Hospital, testing the effectiveness of lopinavir-ritonavir and hydroxychloroquine.
Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine Off-label prescribing of hydroxychloroquine – or the closely related chloroquine – for prophylaxis of COVID-19 raises a number of potential concerns.